Medicure MCUJF
OTC MCUJF
$1.97 +0.02 (+1.03%)
At close: Sep 29, 2026 · 4:00 PM EDT

Medicure (MCUJF) Return on Equity [ROE] (2009 - 2026)

Updated

Medicure's Return on Equity [ROE] was -58.27% in the quarter ended Jun 30, 2026, down 45.70 percentage points from -12.57% a year earlier but up 2.88 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Return on Equity [ROE] at Medicure came in at -41.61%, down 36.54 percentage points from the prior year.

  • Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -10.08 percentage points (years ended Dec 2020 to Dec 2025).
  • In earlier years, Return on Equity [ROE] was -5.07% in the year ended Dec 31, 2024 (-0.65 pp), -4.42% in the year ended Dec 31, 2023 (-11.23 pp), 6.81% in the year ended Dec 31, 2022 (+10.81 pp) and -4.00% in the year ended Dec 31, 2021 (+27.53 pp).
  • Quarterly Return on Equity [ROE] has moved between -61.14% (the quarter ended Mar 31, 2026) and 11.63% (the quarter ended Sep 30, 2022) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has declined for six straight quarters, with an average year-over-year change of -25.87 percentage points over the last seven quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was the quarter ended Sep 30, 2022 (a gain of 39.97 percentage points); the worst was the quarter ended Mar 31, 2026 (a drop of 53.29 percentage points).
  • Per Business Quant data, MCUJF's Return on Equity [ROE] in the three quarters before the quarter ended Jun 30, 2026 was -61.14% (quarter ended Mar 31, 2026), -53.63% (quarter ended Dec 31, 2025) and -25.00% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Medicure 205.60 Mn 197.40 Mn 2.31 Mn -58.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58.27%
Mar 31, 2026 -61.14%
Dec 31, 2025 -53.63%
Sep 30, 2025 -25.00%
Jun 30, 2025 -12.57%
Mar 31, 2025 -7.85%
Dec 31, 2024 -1.52%
Sep 30, 2024 -6.68%
Jun 30, 2024 -7.20%
Mar 31, 2024 -0.93%
Dec 31, 2023 -2.15%
Mar 31, 2023 0.88%
Dec 31, 2022 1.08%
Sep 30, 2022 11.63%
Jun 30, 2022 -2.52%
Mar 31, 2022 -2.85%
Dec 31, 2021 -11.94%
Sep 30, 2021 -28.34%
Jun 30, 2021 -24.85%
Mar 31, 2021 -27.67%
API Access

Medicure Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MCUJF&period=max&api_key=YOUR_API_KEY